Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil

Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development

(2011) Lucas H Sampaio et al.   BMC INFECTIOUS DISEASES

Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers

(2011) M. S. Duthie et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Successes and failures in the control of infectious diseases in Brazil: social and environmental context, policies, interventions, and research needs

(2011) Mauricio L Barreto et al.   LANCET

Analysis of Antibody Responses toMycobacterium lepraePhenolic Glycolipid I, Lipoarabinomannan, and Recombinant Proteins To Define Disease Subtype-Specific Antigenic Profiles in Leprosy

(2010) John S. Spencer et al.   Clinical and Vaccine Immunology

Enhancing Sensitivity of Detection of Immune Responses to Mycobacterium leprae Peptides in Whole-Blood Assays

(2010) A. Geluk et al.   Clinical and Vaccine Immunology

A Major Gene Controls Leprosy Susceptibility in a Hyperendemic Isolated Population from North of Brazil

(2010) Fernando P. Lázaro et al.   JOURNAL OF INFECTIOUS DISEASES

Rational Design and Evaluation of a Multiepitope Chimeric Fusion Protein with the Potential for Leprosy Diagnosis

(2009) M. S. Duthie et al.   Clinical and Vaccine Immunology

From Genome-Based In Silico Predictions to Ex Vivo Verification of Leprosy Diagnosis

(2009) A. Geluk et al.   Clinical and Vaccine Immunology

Selection of Antigens and Development of Prototype Tests for Point-of-Care Leprosy Diagnosis

(2008) M. S. Duthie et al.   Clinical and Vaccine Immunology

Antigen-Specific T-Cell Responses of Leprosy Patients

(2008) M. S. Duthie et al.   Clinical and Vaccine Immunology